Literature DB >> 29678756

New Crosslinked Hyaluronan Gel for the Prevention of Intrauterine Adhesions after Dilation and Curettage in Patients with Delayed Miscarriage: A Prospective, Multicenter, Randomized, Controlled Trial.

Xueying Li1, Ling Wu1, Yanfei Zhou2, Xing Fan2, Jufang Huang3, Juhua Wu3, Renxiu Yu4, Jianying Lou4, Mengjie Yang5, Zhihong Yao6, Min Xue7.   

Abstract

STUDY
OBJECTIVES: To evaluate the efficacy of a new crosslinked hyaluronan (NCH) gel in reducing the formation of intrauterine adhesions (IUAs) after dilation and curettage (D&C).
DESIGN: Randomized controlled trial (Canadian Task Force classification I). SETTINGS: Six hospitals for maternal and child healthcare in China. PATIENTS: A total of 300 patients were randomized to undergo D&C for delayed miscarriage without previous history of D&C. Twenty-six patients (9%) were lost to follow-up and were excluded from the analysis.
INTERVENTIONS: Women were randomly assigned to D&C alone (control group; n = 150) or D&C plus NCH gel application (NCH gel group; n = 150) with 1:1 allocation.
MEASUREMENTS AND MAIN RESULTS: All patients were evaluated using the American Fertility Society classification of IUAs during follow-up diagnostic hysteroscopy, scheduled at 3 months after D&C procedure. The primary endpoint was the number of women with IUAs at 3 months, and the secondary endpoints were adhesion scores and severity of IUAs. Postoperative efficacy data were available for 274 women (137 in each group). Intrauterine adhesion formations were observed in 13 of the 137 women (9.5%) in the NCH gel group and in 33 of the 137 women (24.1%) in the control group (p = .0012; relative risk [RR], 0.3939; 95% confidence interval [CI], 0.2107-0.7153), a difference of 14.6% (95% CI, 5.92%-23.28%) between the 2 groups. The extent of intrauterine cavity involved, type of adhesion and menstrual pattern, and cumulative adhesion scores were significantly lower in the NCH gel group compared with the control group (p = .0007, .008, .0012, and .0006, respectively). The proportion of women with moderate to severe IUAs was significantly lower in the NCH gel group than that in the control group (1 of 137 [0.7%] vs 16 of 137 [11.7%]; p = .0002; RR, 0.0625; 95% CI, 0.0084-0.4648), a difference of 11.95% (95% CI, 5.39%-16.51%) between the 2 groups.
CONCLUSIONS: The current study demonstrates that IUAs are frequently formed after D&C for delayed miscarriage in women without a previous history of D&C procedures, and the application of NCH gel significantly reduces IUA formation.
Copyright © 2018 American Association of Gynecologic Laparoscopists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  American Fertility Society classification; Crosslinked hyaluronan gel; Hyaluronic acid gel

Mesh:

Substances:

Year:  2018        PMID: 29678756     DOI: 10.1016/j.jmig.2018.03.032

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  10 in total

1.  Effect of hysteroscopic adhesiolysis on recurrence, menstruation and pregnancy outcomes in patients with different degrees of intrauterine adhesions.

Authors:  Lu Wang; Chen Guo; Huabin Cao
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Comparison of Autocross-Linked Hyaluronic Acid Gel and Intrauterine Device for Preventing Intrauterine Adhesions in Infertile Patients: A Randomized Clinical Trial.

Authors:  Yu-Qing Wang; Xiao-Hua Song; She-Ling Wu; Yu-Zhen Huang; Lei Yan; Chang-Zhong Li
Journal:  Gynecol Minim Invasive Ther       Date:  2020-04-28

3.  New Crosslinked Hyaluronan Gel, Intrauterine Device, or Both for the Prevention of Intrauterine Adhesions.

Authors:  Emre G Pabuçcu; Ertuğ Kovanci; Özgür Şahin; Esra Arslanoğlu; Yiğit Yıldız; Recai Pabuçcu
Journal:  JSLS       Date:  2019 Jan-Mar       Impact factor: 2.172

4.  Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions after a Hysteroscopic Myomectomy in Women with Submucosal Myomas: A Prospective, Randomized, Controlled Trial.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Min Cheng; Hsin-Yi Huang; Huann-Cheng Horng; Yi-Jen Chen; Wen-Ling Lee; Peng-Hui Wang
Journal:  Life (Basel)       Date:  2020-05-15

5.  Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial.

Authors:  Angelo B Hooker; Robert A de Leeuw; Jos W R Twisk; Hans A M Brölmann; Judith A F Huirne
Journal:  Hum Reprod       Date:  2021-01-01       Impact factor: 6.918

6.  A randomized controlled study on an integrated approach to prevent and treat re-adhesion after transcervical resection of moderate-to-severe intrauterine adhesions.

Authors:  Li-Zhen Pan; Ying Wang; Xian Chen
Journal:  Clinics (Sao Paulo)       Date:  2021-05-05       Impact factor: 2.365

7.  Chemically Modified Hyaluronic Acid for Prevention of Post-Surgical Adhesions: New Aspects of Gel Barriers Physical Profiles.

Authors:  Luz Angela Torres-de la Roche; Véronique Bérard; Maya Sophie de Wilde; Rajesh Devassy; Markus Wallwiener; Rudy Leon De Wilde
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

Review 8.  Recent progress of Bioinspired Hydrogel-based delivery system for endometrial repair.

Authors:  Rong Dong; Saihua Ma; Xiaoli Zhao; Baojuan Wang; Mridul Roy; Lu Yao; Tian Xia; Yanting Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-09

Review 9.  Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision.

Authors:  Wen-Ling Lee; Chia-Hao Liu; Min Cheng; Wen-Hsun Chang; Wei-Min Liu; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  Methods for managing miscarriage: a network meta-analysis.

Authors:  Jay Ghosh; Argyro Papadopoulou; Adam J Devall; Hannah C Jeffery; Leanne E Beeson; Vivian Do; Malcolm J Price; Aurelio Tobias; Özge Tunçalp; Antonella Lavelanet; Ahmet Metin Gülmezoglu; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.